tirzepatide and kidney disease Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial

Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management

29.94

★★★★☆4.8 (126)

SURPASS-4: Tirzepatide slows kidney disease in adults with type 2 diabetes, CV risk

27.59

★★★★★4.9 (98)

This isn't just a weight loss shot… 👀 Tirzepatide is changing the way we think about metabolism, heart health, and even kidney protection. Swipe to see what's really happening inside your body

23.46

★★★★★5.0 (157)

Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial

28.35

★★★★★4.7 (84)

Can tirzepatide (Zepbound) be used in a patient with chronic kidney disease and an estimated glomerular filtration rate of 28 mL/min/1.73 m², and what dosing and monitoring recommendations are appropriate?

23.34

★★★★★4.9 (203)

Tirzepatide (Zepbound) showed improved kidney function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https

20.69

★★★★★5.0 (176)

Tirzepatide Prescribing Practices and Efficacy in Patients with Diabet | DMSO

28.80

★★★★★4.8 (132)